Skip to main content
. 2014 Sep 10;2014(9):CD003723. doi: 10.1002/14651858.CD003723.pub3

Summary of findings 2. Lorazepam IV versus diazepam plus phenytoin IV for status epilepticus.

Lorazepam IV versus diazepam plus phenytoin IV for status epilepticus
Patient or population: patients with status epilepticus
 Settings:Intervention: Lorazepam IV versus diazepam plus phenytoin IV
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) No of Participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
Control Lorazepam IV versus diazepam plus phenytoin IV
Non‐cessation of seizures Study population RD ‐0.04 
 (‐0.35 to 0.26) 370
 (2 studies) ⊕⊕⊝⊝
 low1,2,3  
227 per 1000 179 per 1000 
 (127 to 257)
Moderate
221 per 1000 175 per 1000 
 (124 to 250)
Adverse effects Study population RR 0.85 
 (0.63 to 1.15) 370
 (2 studies) ⊕⊕⊕⊝
 moderate1,3  
290 per 1000 246 per 1000 
 (182 to 333)
Moderate
281 per 1000 239 per 1000 
 (177 to 323)
Deaths See comment See comment Not estimable 178
 (1) See comment Reported in a single study
Requirement of Ventilatory support See comment See comment Not estimable 178
 (1) See comment Reported in a single study
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: Confidence interval; IV: intravenous; RR: Risk ratio.
GRADE Working Group grades of evidence
 High quality: Further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: We are very uncertain about the estimate.

1 Even though one study did not have a clear concealment of allocation, this is possibly a lack of reporting. Lack of blinding in this study is unlikely to bias the outcome assessment as the outcomes are clearly detectable and objective.
 2 The I square is 95%.
 3 The number of events is small and confidence interval is wide.